Establishment Labs Holdings Inc. income statement

In fiscal 2025, Establishment Labs Holdings Inc. reported revenue of $211m, up 27.1% on the year before, operating income of −$39.0m (a -18.5% margin) and net income of −$51.1m, or −$1.72 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Establishment Labs Holdings Inc.: income statement, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	35	61	90	85	127	162	165	166	211	246
Cost of revenue	17	25	35	32	41	55	58	57	65	73
Gross profit	18	36	55	53	85	107	107	110	146	173
Research and development	7	13	15	14	18	20	26	20	20	20
Selling, general and administrative	31	47	71	67	92	126	146	140	165	172
Operating income	−20	−24	−31	−28	−25	−40	−65	−50	−39	−19
Interest expense	10	9	9	9	9	12	15	21	25	28
Income before tax	−35	−21	−38	−38	−40	−73	−79	−85	−58	−47
Income tax	0	0	1	0	1	2	−0	−0	−7	−9
Net income	−35	−21	−38	−38	−41	−75	−79	−85	−51	−39
Diluted EPS	−$3.41	−$1.22	−$1.86	−$1.63	−$1.72	−$3.08	−$3.07	−$3.00	−$1.72	−$1.29
Diluted shares (average)	10m	17m	21m	23m	24m	24m	26m	28m	30m	30m
EBITDA	—	—	—	—	−23	−37	−62	−45	−33	—

US$ millions unless shown otherwise. Fiscal quarters.

Establishment Labs Holdings Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	40	45	41	51	54	65	60	68
Cost of revenue	15	14	14	16	16	19	18	20
Gross profit	26	30	28	35	38	46	42	48
Research and development	5	5	5	5	5	5	5	5
Selling, general and administrative	34	44	40	44	37	44	44	47
Operating income	−13	−19	−17	−14	−4	−4	−7	−4
Interest expense	5	6	6	6	6	7	7	7
Income before tax	−16	−36	−20	−16	−11	−12	−13	−12
Income tax	1	−1	1	1	0	−9	0	0
Net income	−17	−35	−21	−17	−11	−3	−13	−12
Diluted EPS	−$0.59	−$1.20	−$0.70	−$0.57	−$0.38	−$0.08	−$0.45	−$0.39
EBITDA	−12	−17	−15	−13	−3	−2	−5	—

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CERS vs ESTA ESTA vs LMAT ESTA vs KIDS ESTA vs SIBN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Establishment Labs Holdings Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Establishment Labs Holdings Inc.